|
|
|
|
|
by sytelus
1521 days ago
|
|
I think this is great and not often looked way to diversity. They are selling at 20X annual earnings (or 5% annual returns) and have track record of producing earnings for over 100 years. Additionally, royalty is brand dependent (it seems), not whether Listerine actually uses formula. Also, this is regular consumable that is unlikely to get displaced anytime soon. The best thing about it is that it is inflation protected. Not a bad deal to diversity in low-risk, low-return zone. |
|
A 5% return royalty is largely illiquid, can not likely be collateralized at a low interest rate, has limited ability to appreciate in value, etc. etc.
I don't see it as that valuable...especially with the decline of major CPG brands. The remaining risk with this investment is completely unknown to me.